Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

NCT00001302 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT00001302
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001302 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Completed
Start date
September 30, 1992
Completion date
June 30, 2002
Enrollment
80
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, kidney neoplasm, lymphoma, neoplasm metastasis, ovarian cancer